The Energy Code

Dr. Mike Belkowski
  • 4.8 (128)
  • Alternative Health
  • Updated Weekly

The Energy Code is your blueprint for unlocking limitless vitality at the cellular level. Hosted by Dr. Mike Belkowski, this podcast dives deep into the science of your mitochondria—the true engines of health and energy. From light, water, and magnetism to groundbreaking molecules and lifestyle upgrades, each episode decodes the most effective strategies to strengthen your “Mitochondrial Matrix.” If you’re seeking cutting-edge science, practical tools, and proven methods to optimize your body and mind, you’ve just cracked the code. Check out these sources: www.biolight.shop – Instagram @biolight.shop – YouTube BioLight

  1. 23h ago

    Humanin: The Longevity Peptide Hidden Inside Your Mitochondria

    In this peptide-focused Deep Dive, Dr. Mike explores Humanin, one of the most fascinating and underappreciated mitochondrial-derived peptides in the longevity space. First discovered in 2001 while researchers were searching for molecules that could protect neurons from Alzheimer’s-related toxicity, Humanin appears to act as one of the body’s natural cellular survival signals — helping cells withstand oxidative stress, inflammation, mitochondrial damage, metabolic dysfunction, and age-related decline. This episode breaks down a 2023 systematic review from Biology titled “Humanin and Its Pathophysiological Roles in Aging”, covering Humanin’s unusual mitochondrial origin, its role in neuroprotection, mitohormesis, chaperone-mediated autophagy, metabolic health, cardiovascular function, inflammation, and lifespan research. Dr. Mike also explains why Humanin may deserve a place alongside SS-31 and MOTS-c as one of the top mitochondrial peptides for anyone interested in mitochondrial wellness, resilience, and longevity. (Educational content only, not medical advice.) - Article Discussed in Episode: Humanin and Its Pathophysiological Roles in Aging: A Systematic Review - Key Quotes From Dr. Mike: “Humanin was originally isolated from surviving neurons in the brains of patients with Alzheimer’s disease" "It was named 'Humanin' to reflect its potential role in preserving human health and survival."  “Humanin appears to function as one of the body’s natural cellular survival signals... acting as a molecular shield and mitokine." “Humanin restores the communication link that tells the cleanup crew exactly where the toxic debris is hiding.” “By addressing the mitochondrial origin of this inflammation — the leaky battery problem — Humanin hits multiple diseases simultaneously.” "These are the top three peptides if you’re a mitochondriac: SS-31, MOTS-c, and now you can see why the third is Humanin.” - Key Points ⚡ Humanin is a small mitochondrial-derived peptide first discovered in 2001 during research into Alzheimer’s disease-related neuronal protection. ⚡ It was originally isolated from surviving neurons in the brains of Alzheimer’s patients, which helped shape its identity as a cellular survival peptide. ⚡ Humanin is encoded within the mitochondrial genome, specifically inside the 16S ribosomal RNA gene, giving mitochondria their own “voice” beyond ATP production. ⚡ It exists in two forms: a 21-amino-acid version when translated in mitochondria and a 24-amino-acid version when translated in the cytoplasm. ⚡ Humanin is highly conserved across species, suggesting it may play a fundamental role in multicellular survival and stress resistance. ⚡ It may protect against Alzheimer’s-related toxicity by interfering with amyloid beta toxicity and blocking pro-apoptotic pathways like Bax activation. ⚡ Humanin functions as a mitokine, released during periods of mitochondrial stress to coordinate resilience across cells and tissues. ⚡ Humanin levels generally decline with age, although some very old individuals may show compensatory spikes as a last-ditch mitohormetic stress response. ⚡ It supports chaperone-mediated autophagy, helping the cell’s “precision cleanup crew” remove damaged or oxidized proteins. ⚡ Humanin has broad systemic effects, including potential benefits for brain health, cardiovascular aging, insulin sensitivity, visceral fat, lean mass, inflammation, stem cell survival, and reproductive health. ⚡ Animal models suggest even modest increases in circulating Humanin may provide protection against toxic insults and inflammatory markers. ⚡ A synthetic analog called HNG / Humanin S14G may be up to 1,000 times more potent than naturally occurring Humanin in certain models. ⚡ Dr. Mike frames Humanin as the third part of a mitochondrial peptide “big three” alongside SS-31 and MOTS-c. - Episode timeline 0:00–0:40 — Introduction to Humanin as another mitochondrial-derived peptide; article title and source 0:40–1:47 — Historical overview: Humanin discovery in 2001, Alzheimer’s research, and the birth of mitochondrial-derived peptide science 1:47–3:23 — Humanin’s potential benefits: mitochondrial function, oxidative stress protection, metabolism, brain health, inflammation, stem cells, fertility, and cellular resilience 3:23–4:52 — Big-picture framing: Humanin as a cellular survival signal and ancient mitochondrial communication molecule 4:52–6:55 — Section 1: Humanin as an ancient signal from the mitochondrial genome; 16S rRNA origin, two peptide lengths, evolutionary conservation 6:55–8:04 — Section 2: Alzheimer’s origin story; Humanin as a neuroprotective molecule that interferes with amyloid beta and apoptotic pathways 8:04–9:15 — Section 3: Mitohormesis; Humanin as a stress-responsive mitokine and possible last-ditch survival signal in advanced age 9:15–10:35 — Section 4: Chaperone-mediated autophagy; Humanin as the “supervisor” of cellular cleanup and damaged protein removal 10:35–12:00 — Section 5: Pleiotropic effects beyond the brain: heart, diabetes, metabolism, inflammation, inflammaging 12:00–13:32 — Section 6: Lifespan and health span research; 16% circulating Humanin increase, C. elegans lifespan, FOXO/IGF-1 pathway, and HNG analog 13:32–14:32 — Review conclusion: aging as a breakdown in ancient mitochondrial signaling rather than inevitable wear and tear 14:32–16:26 — Dr. Mike’s viewpoint: Humanin as underappreciated, part of the top three mitochondrial peptides with SS-31 and MOTS-c - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

    18 min

  2. 1d ago

    BPC-157: A “Miracle” Healing Peptide or Gray-Market Hype?

    In this episode of The Energy Code, Dr. Mike Belkowski breaks down BPC-157, one of the most popular and debated peptides in the wellness, recovery, and biohacking worlds. He covers its origins as a synthetic fragment of a protective compound found in gastric juice, its potential roles in tendon, ligament, muscle, gut, nerve, and tissue repair, and the major caveat around angiogenesis. The episode then unpacks a recent Pharmaceutics review highlighting the central paradox of BPC-157: decades of compelling animal data and powerful anecdotal reports, but still a major lack of rigorous human clinical evidence, standardized formulations, and long-term safety data. Ultimately, BPC-157 is framed as a high-potential, low-certainty peptide — promising enough to deserve serious attention, but not yet proven enough to justify blind faith. (Educational content only, not medical advice.) - Article Discussed in Episode: BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers - Key Quotes From Dr. Mike: “BPC-157 has been investigated primarily through studies looking at gastrointestinal protection, tissue repair, and healing mechanisms.” “BPC-157’s gastric stability does not equal oral bioavailability… “The claim that oral BPC-157 reaches systemic circulation is an unverified hypothesis, not a clinical fact.” “It enters the blood, triggers a response, and is cleared by the kidneys almost instantly. Yet its healing effects can persist for days or weeks.” “There are over 544 peer-reviewed studies, mostly in rodents… In terms of total human efficacy subjects, there’s fewer than 30 people documented in all history.” “For now, BPC-157 remains the ultimate biological paradox: a compound that can seemingly heal anything in the lab, but officially nothing in the clinic.” - Key Points ⚡ BPC-157 stands for Body Protecting Compound 157 and is derived from a protective protein found in human gastric juice. ⚡ It has been studied mostly in animal models for tissue repair, tendon healing, ligament recovery, muscle injury, gut protection, angiogenesis, nerve support, inflammation modulation, and oxidative stress reduction. ⚡ Despite its popularity, BPC-157 has almost no robust human clinical data. ⚡ A recent Pharmaceutics review describes BPC-157 as an investigational peptide with major formulation, pharmacokinetic, regulatory, and translational barriers. ⚡ BPC-157 is unusually stable in acidic stomach-like environments, but gastric stability does not prove oral bioavailability. ⚡ Its systemic half-life appears to be under 30 minutes, yet animal studies suggest effects may last days or weeks, creating a major pharmacokinetic/pharmacodynamic mystery. ⚡ The review suggests BPC-157 may act as a transcriptional primer, briefly triggering gene and growth-factor cascades that continue after the peptide is cleared. ⚡ The evidence base is heavily skewed toward preclinical animal studies, with very limited human data. ⚡ Much of the BPC-157 literature comes from one research group at the University of Zagreb, creating a need for independent replication. ⚡ BPC-157’s native stability may make it difficult to patent, reducing pharmaceutical incentive to fund large clinical trials. ⚡ Current gray-market products are research chemicals, not FDA-approved pharmaceutical-grade human therapeutics. ⚡ Potential risks include inconsistent dosing, lack of GMP oversight, lack of long-term safety data, and theoretical concern around angiogenesis in the setting of hidden malignancy. ⚡ Dr. Mike’s view: BPC-157 has earned scientific curiosity, but not scientific certainty. - Episode timeline 0:00 – Introduction to BPC-157 Dr. Mike introduces BPC-157 as one of the most popular peptides outside the GLP-1 category and explains that BPC stands for Body Protecting Compound 157.   0:49 – The Review Being Covered The episode centers on a recent Pharmaceutics review titled BPC 157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers.   1:20 – Brief History of BPC-157 BPC-157 is described as a synthetic peptide derived from a protective protein naturally found in human gastric juice, with research beginning in the 1990s.   2:05 – Anecdotal Use and Recovery Claims Dr. Mike discusses how BPC-157 is often used anecdotally for soft-tissue injuries, chronic pain, muscle strains, tendons, ligaments, cartilage, and athletic recovery.   2:45 – Potential Benefits The episode outlines possible benefits including tendon repair, ligament recovery, muscle healing, wound healing, gut protection, joint support, angiogenesis, inflammation reduction, oxidative stress modulation, nerve regeneration, and overuse injury recovery.   3:36 – Angiogenesis Caveat Dr. Mike notes that while blood vessel formation can support healing, it may theoretically be problematic in the presence of active or hidden cancer.   4:11 – The Phantom Peptide BPC-157 is framed as a paradox: one of the most popular experimental peptides with decades of animal data but almost no validated human evidence.   5:42 – The Gastric Survivor The review highlights BPC-157’s unusual stability in acidic gastric environments, while emphasizing that stomach stability does not equal proven oral absorption.   7:25 – The 30-Minute Phantom Dr. Mike explains the pharmacokinetic/pharmacodynamic disconnect: BPC-157 appears to clear rapidly, yet may trigger longer-lasting biological effects.   8:49 – The 554-to-1 Evidence Gap The episode breaks down the huge imbalance between preclinical studies and human clinical data, including fewer than 30 documented human efficacy subjects.   9:35 – The Zagreb Paradox Much of the BPC-157 literature comes from a single research group at the University of Zagreb, creating a major need for independent replication.   10:15 – Armor Made of Proline BPC-157’s structural durability is explained through its proline-rich sequence, which may help protect it from enzymatic breakdown.   10:47 – Why Big Pharma May Not Be Interested Because BPC-157 is natively stable and difficult to patent as a new chemical entity, there may be limited financial incentive for large pharmaceutical trials.   11:48 – Regulatory Limbo The episode discusses gray-market availability, lack of pharmaceutical-grade versions, research-chemical status, and possible FDA scrutiny.   13:23 – What BPC-157 Needs Next Dr. Mike explains the need for validated LC-MS/MS methods, ICH Q1A stress testing, and independent replication of the Zagreb data.   15:18 – Dr. Mike’s Viewpoint BPC-157 is described as neither miracle nor fraud, but a promising yet uncertain compound that deserves open-minded skepticism.   16:55 – Scientific Curiosity vs. Scientific Certainty The episode closes by emphasizing that BPC-157 has compelling preclinical evidence and strong anecdotal support, but still lacks definitive human evidence. - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

    20 min

  3. 5d ago

    The Energy Code Blueprint: Longevity Starts in the Mitochondria, Pt. 2

    In Part 2 of Dr. Mike's podcast special of his presentation from Dave Asprey's BEYOND Biohacking Conference, we finish all six pillars of mitochondrial wellness — from mitophagy (quality control) & mitochondrial dynamics (fusion/fission balance) to ROS intelligence (selective antioxidant strategy) & light (red/NIR as the master signal). Then we move from theory to action: the episode begins the “applications” section with a practical, research-backed toolkit — red light therapy, methylene blue, blue spirulina, & Carbon 60 — including how they work, how they stack, & why the right strategy is less about “more antioxidants” & more about restoring electron flow, managing oxidative stress, & building cellular resilience. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: “If mitophagy is not working properly, then those damaged mitochondria are allowed to linger and be pro-inflammatory and be pro-oxidative stress.” “Specifically, red and near-infrared are the spectra that excites the mitochondria and the cytochrome c oxidase. No other wavelengths accomplish this.” “Simply by exposing your body… to red and near-infrared light (whether sun or red light therapy devices)… this is likely the most powerful way to remedy mitochondrial dysfunction.” “Methylene blue is one of the only ways I know of that’s able to actually restore energy in mitochondria with broken electron transport chains.” “We have an amazing natural alternative to methylene blue… and that is blue spirulina, which has phycocyanins that absorbs red light to protect neurons and strengthen our mitochondrial performance.” “Carbon 60 is essentially a free radical sponge… it’s only gonna remove the excess ‘bad’ free radicals and allow the good signaling molecules to stay.” - Key Points ⚡️ Mitophagy = mitochondrial quality control: PINK1 “inspects,” Parkin “tags,” autophagosomes “remove.” When it fails, damaged mitochondria linger & inflammation/oxidative stress snowball. ⚡️ Dysfunctional mitochondria can self-propagate, accelerating decline unless quality control is restored. ⚡️ Mitochondrial dynamics (fusion/fission) is a Goldilocks game: Too much fission → fragmentation & energy collapse Too much fusion → damage spreading through hyperfusion ⚡️ ROS aren’t “all bad”: low-level ROS are essential signals; the goal is selective antioxidant defense, not blanket quenching. ⚡️ Light is a mitochondrial master regulator: red/NIR stimulate cytochrome c oxidase, dissociate nitric oxide, allow oxygen back in → better ATP + EZ water. ⚡️ Red light therapy is wavelength-driven, not “power-driven”: red = skin; NIR = deeper tissues; power mainly affects time-to-dose. ⚡️ Methylene blue = electron chaperone: bypasses ETC bottlenecks (esp. complex I/III) by shuttling electrons toward complex IV; synergizes with red light. ⚡️ Blue spirulina (phycocyanin) = natural photodynamic partner: less potent than MB but strong synergy with red light; quality matters (E10→E40). ⚡️ Carbon 60 = selective free radical sponge: mops up “excess” ROS while preserving beneficial signaling; quality control is crucial. - Episode timeline 0:00–2:00 — Why this “Part 2” exists (no event time limit) + recap: bioenergetics + pillars 1–2 from Part 1 2:00–8:30 — Pillar 3: Mitophagy (PINK1/Parkin, why failure drives disease, self-propagation, urolithin A mention) 8:30–12:45 — Pillar 4: Mitochondrial dynamics (fusion vs fission, benefits, dangers of imbalance) 12:45–16:30 — Pillar 5: ROS protection (signal vs damage, selective antioxidants, why “antioxidant overload” backfires) 16:30–25:00 — Pillar 6: Light (cytochrome c oxidase, NO vs oxygen competition, why red/NIR are special, darkness as a mitophagy signal) 25:00–33:00 — Applications begin: Red light therapy (wavelength vs penetration, power vs efficiency, dosing logic, third-party testing) 33:00–41:45 — Methylene blue (electron chaperone + regenerative redox cycling + brain affinity + SSRI nuance + photodynamic synergy) 41:45–46:45 — Blue spirulina (phycocyanin, how to use, why E40 matters, timing before light) 46:45–54:45 — ESS60 / Carbon 60 (selective ROS sponge, quality warnings, classic longevity study discussion, why it completes the “triad”) 54:45–end — Why this becomes a 3-parter + what’s coming next (remaining applications + “Energy Code Blueprint” day/week examples) - Introducing BioLight Labs! For years, BioLight has been dedicated to advancing mitochondrial wellness through education, red and near-infrared light therapy, methylene blue, and targeted nutritional solutions.   Our initial offerings will focus on some of the most promising peptides in the fields of healthy aging, cellular resilience, recovery, and mitochondrial function, with many more innovative compounds and educational resources to come.   BioLight Labs was created to serve researchers, practitioners, and health enthusiasts seeking the next frontier of bioenergetic optimization.   The future of wellness is bioenergetic. The future is BioLight Labs.   Explore BioLight Labs → - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

    58 min

  4. Jun 8

    MOTS-c: The ‘Exercise Mimetic’ Peptide That Rewires Metabolism, Fat Loss, and Mitochondrial Resilience

    In this peptide-focused Deep Dive, Dr. Mike moves from SS-31 to MOTS-c — one of the most popular mitochondrial-derived peptides for metabolic resilience and mitochondrial wellness. You’ll get a fast, practical primer (what it is + key benefits), then a walkthrough of a review titled “MOTS-c Functionality Prevents Metabolic Disorders,” explaining how MOTS-c acts as a mitochondrial “telegram” to your DNA via retrograde signaling. The episode breaks down MOTS-c’s “exercise mimetic” mechanisms (AMPK activation via AICAR), its reported effects across metabolism, muscle, bone, immune aging, and senescence clearance, and finishes with an actionable playbook for supporting endogenous MOTS-c through mitohormetic lifestyle inputs — and a thoughtful strategy for stacking MOTS-c with SS-31. (Educational content only, not medical advice.) - Article Discussed in Episode: MOTS-c Functionally Prevents Metabolic Disorders - Key Quotes From Dr. Mike: “MOTS-c… helps regulate cellular energy production, metabolic flexibility, and stress adaptation.” “MOTS-c functionally prevents metabolic disorders.” “When the cells are under metabolic stress, MOTS-c… can be rapidly transferred from mitochondria to the nucleus and regulates nuclear gene expression.” “Because MOTS-c is easily destroyed by digestive enzymes, oral delivery remains a significant challenge…” “Some researchers view MOTS-c as a mitochondrial distress signal… mitochondria release more MOTS-c when challenged, not when everything is perfectly comfortable.” “If you want the best of both worlds (for mitochondrial optimization)... stack SS-31 and MOTS-c together.” - Key Points SS-31 and MOTS-c are framed as the “top two” mitochondrial peptides (SS-31 = not mitochondrially-derived but highly mito-targeted; MOTS-c = mito-derived). MOTS-c is positioned as a mitochondrial optimization + metabolic flexibility peptide and an “exercise mimetic.” Core benefits highlighted: energy production, glucose utilization/insulin sensitivity, body composition, endurance/recovery, stress adaptation, longevity support. Big concept: mitochondria aren’t passive; they signal back to the nucleus. MOTS-c can translocate to the nucleus under metabolic stress and regulate gene expression. Mechanism highlighted: MOTS-c disrupts folate–methionine cycle → increases AICAR → activates AMPK → boosts fatty acid oxidation + insulin sensitivity. Review claims include: prevention of diet-induced obesity; possible cardiac protection against remodeling (NRG1–ERBB4 pathway mentioned). Longevity genetics angle: a mitochondrial polymorphism (noted as prevalent in Japanese population) may alter MOTS-c structure and associate with exceptional lifespan. Frailty/bone/muscle: MOTS-c described as inhibiting FOXO1 (muscle wasting signals), supporting myotube formation (STAT3), and reducing osteoclast differentiation (anti-osteoporosis). “Endogenous edge”: as a bioidentical peptide, MOTS-c is framed as potentially less immunogenic than some drugs, but oral delivery is a challenge due to peptide fragility. Practical close: best endogenous stimuli are mitochondrial challenges—exercise, fasting, heat/cold, hypoxia—plus circadian alignment and mitochondrial support nutrients. - Episode timeline 0:00–1:55 — Transition from SS-31 to MOTS-c; why MOTS-c is a “top two” peptide; new format: quick primer before the paper 1:55–4:33 — MOTS-c snapshot: what it is + core benefits list (metabolism, insulin sensitivity, fat loss, endurance, longevity) 4:33–7:57 — Review intro: mitochondria as control centers; retrograde signaling; MOTS-c as a mitochondrial messenger to DNA 7:57–10:44 — “Exercise mimetic” mechanism: folate–methionine cycle → AICAR → AMPK; obesity/metabolic protection examples 10:44–12:05 — Longevity genetics: MOTS-c polymorphism + “nature vs nurture” discussion 12:05–13:52 — Frailty defense: muscle (FOXO1/STAT3), bone (osteoclast suppression; OPG/RANKL mention) 13:52–15:46 — Endogenous/bioidentical angle; immune aging + senescent cell clearance; oral delivery limitations 15:46–19:31 — How to boost endogenous MOTS-c: exercise intensity, fasted training nuance, AMPK activators, TRE/IF/CR 19:31–24:25 — Cold/heat/circadian alignment + mitochondrial support stack (taurine, urolithin A, CoQ10, PQQ, etc.) 24:25–26:10 — “Distress signal” nuance: mitochondria release more MOTS-c when challenged 26:10–29:41 — Practical stacking: SS-31 first (engine repair) → add MOTS-c; daily timing suggestions; closing message - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

    31 min

  5. Jun 5

    SS-31: The Peptide ‘Mitochondrial Shield’ That May Block Parkinson’s Damage at the Source

    This is the first dedicated peptide deep dive of The Energy Code — and it starts with arguably the most mitochondrial-centric peptide on the board: SS-31 (Elamipretide). Dr. Mike breaks down a new paper showing how SS-31 may protect neurons in Parkinson’s disease by competing with alpha-synuclein at lipid membranes, slowing toxic aggregation, restoring mitochondrial respiration, and even reducing alpha-synuclein cellular entry. You’ll also hear a key caution: SS-31 appears highly protective at moderate doses, but too much may flip the benefit into harm, reinforcing the “dose makes the medicine” rule in mitochondrial pharmacology. (Educational content only, not medical advice.) - Article Discussed in Episode: Therapeutic Peptide SS-31 Modulates Membrane Binding and Aggregation of α-Synuclein and Restores Impaired Mitochondrial Function - Key Quotes From Dr. Mike: “The future of Parkinson’s therapy may not lie in cleaning up the mess, but rather in providing our neurons with a permanent molecular shield…” “SS-31 acts as a molecular shield protecting the brain’s energy supply…” “SS-31 acts as a molecular bouncer, physically evicting alpha-synuclein from lipid membranes…” “SS-31 substantially prolonged the lag phase of aggregation, essentially stalling the clock on protein buildup.” “These findings underscore the multifaceted protective role of SS-31 against mitochondrial dysfunction caused by alpha synuclein aggregation... SS-31 reversed this decline with a 10 micromolar dose…” - Key Points SS-31 is framed as a mitochondria-first peptide: “restore impaired mitochondrial function” is the headline. Parkinson’s pathology is presented as a cellular power failure inside dopaminergic neurons driven by alpha-synuclein toxicity. SS-31 may act like a “molecular bouncer” — outcompeting alpha-synuclein for anionic lipid membranes and preventing harmful binding/folding. The episode highlights the real-world complication: N-terminal acetylated alpha-synuclein (common in humans) embeds deeper and is harder to displace. SS-31 appears to delay aggregation kinetics (longer “lag phase”) and shift aggregate morphology toward potentially less toxic off-pathway forms. Mitochondrial function was assessed with a Seahorse mito stress test; SS-31 is described as restoring basal/max respiration (at a cited 10 μM dose). Mechanistically, SS-31 is explained as: Cardiolipin binding → supports OXPHOS efficiency/ATP output ROS scavenging (tyrosine residue) → reduces oxidative damage SS-31 may also reduce alpha-synuclein oligomer uptake by altering membrane electrostatics (less negative surface charge). A major warning: very high concentrations (described as >100 μM) may trigger apoptosis / reduce viability. Big-picture: SS-31 supports a “prevention-first” strategy — block the lipid–protein interaction upstream, rather than “cleaning up the mess” later. - Episode timeline 0:00–0:40 — Why peptides are the next major content focus; why SS-31 is the first peptide deep dive 0:40–3:55 — Paper intro + “SS-31 restores impaired mitochondrial function” framing; what the show will cover and why it matters 3:55–5:44 — Parkinson’s as mitochondrial “power failure”; alpha-synuclein as the driver; SS-31 as a BBB-permeable candidate 5:44–6:58 — Takeaway #1: SS-31 as a “molecular bouncer” displacing alpha-synuclein from membranes (dose-dependent) 6:58–8:16 — Takeaway #2: N-terminal acetylation makes alpha-synuclein “stickier” and harder to displace (real-human relevance) 8:16–9:40 — Takeaway #3: Aggregation kinetics + morphology shifts (stalling the “snowball”) 9:40–11:40 — Takeaway #4–#5: Respiration rescue + membrane/cell-entry effects; the dual mechanism (cardiolipin + ROS) 11:40–13:20 — Dose caution, wrap-up, and the “designer peptides” future-forward conclusion - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

    15 min

  6. Jun 4

    The Energy Code Blueprint: Longevity Starts in the Mitochondria, Pt. 1

    In this special edition of The Energy Code, Dr. Mike shares a more in-depth discussion on his presentation from Dave Asprey’s BEYOND Biohacking event in Austin: The Energy Code Blueprint: Longevity Starts in the Mitochondria. He introduces BioLight Labs’ initial focus on mitochondrial and longevity peptides, then delivers a thorough foundation on bioenergetics — why “more energy per cell” translates to more vitality, how redox/voltage and electrons relate to inflammation, and why mitochondria act as environmental sensors that drive epigenetics. From there, the episode begins the 6 Pillars of Mitochondrial Wellness, covering Pillar 1 (Energy Production ) —including electron transport chain efficiency and EZ water — and Pillar 2 (Mitogenesis) —with key activators like exercise, fasting, cold exposure, PQQ, urolithin A, and red/near-infrared light. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: “The more energy you produce per cell, the more vitality you will have... The less energy you produce per cell, the closer to a state of disease you will be.”“Around 80% of modern diseases are directly tied to mitochondrial dysfunction.”“Any wellness strategy that involves harnessing electrons is inherently anti-aging.”“Epigenetics is rooted in the mitochondria. They sense your environment and then send signals to the cell nucelus, which then turns genes on/off based on those mitochondrial signals."“Cardiolipin… is like the bedrock of mitochondrial function... Many researchers now believe cardiolipin deterioration is one of the central hallmarks of mitochondrial aging.”“SS-31’s mission is to fix and repair and prevent damage to cardiolipin. This makes SS-31 the MOST IMPORTANT peptide for mitochondrial function and anti-aging, from the bioenergetic perspective."“After the age of 30, we typically lose about 1% of energy production annually.”“Mitochondrial decline drives the hallmarks of aging... The future is clearly bioenergetic.” - Key Points ⚡️ Longevity is downstream of bioenergetics: more energy produced per cell → more vitality; less energy → disease trajectory. ⚡️ Mitochondria are upstream of symptoms: dysfunction can precede diagnosis by years/decades. ⚡️  “Healing is Voltage”: redox potential, electron availability, pH, and inflammation are tightly linked. ⚡️ Mitochondria are not just power plants — they are environmental sensors (MIPS) driving epigenetic gene expression via retrograde signaling. ⚡️ Mitohormesis reframes “stress” as a dose-dependent upgrade signal for mitochondria (exercise, fasting, cold/heat, light, key compounds). ⚡️ Cardiolipin is presented as “the mitochondria of the mitochondria,” central to cristae structure, ETC organization, and mitochondrial aging. ⚡️ SS-31 is framed as a top-tier cardiolipin-targeting peptide; MOTS-c, Humanin, SHLP-2 as key mitochondrial-derived peptides. ⚡️ Energy production includes ATP + EZ water: ATP as immediate currency; EZ water as mitochondrial “battery pack” and hydration reserve. ⚡️ Red and near-infrared light are positioned as major tools to expand EZ water and support mitochondria across multiple pillars. ⚡️ The presentation tees up a “6 pillars” framework and promises a next episode continuation (pillars 3–6 + applications). - Episode timeline 00:00–01:55 — Special edition + Beyond Biohacking context; BioLite Labs intro (peptides focus)   01:55–04:52 — Talk format notes + offer to email slides as a resource   04:52–08:54 — Overview: bioenergetics → 6 pillars → optimization strategies → “day in the life” blueprint   08:55–11:02 — Bioenergetics foundation: “more energy per cell = more vitality” (Doug Wallace framing)   11:03–13:50 — Mitochondria as root cause: cells → tissues → organs → systems; symptoms appear late   13:51–17:32 — Voltage/redox: electrons, pH, inflammation; examples (sunlight, grounding, electron-rich strategies)   17:33–19:04 — “Anti-aging via electrons”: shared thread across many wellness strategies   19:07–21:21 — Mitochondria as environmental sensors (MIPS) + retrograde signaling → epigenetics   21:23–24:42 — Mitohormesis: what doesn’t kill mitochondria makes them stronger; key stressors/benefits   24:45–31:56 — Cardiolipin deep dive: cristae structure, fragility to oxidative stress, downstream consequences; SS-31 spotlight   31:57–35:55 — Mitochondrial lens of aging: “energy cliff” concept; mitochondrial decline drives aging hallmarks   36:39–38:00 — “Future is bioenergetic”: move from managing decline to engineering resilience   38:01–40:10 — Six pillars introduced: energy, biogenesis, mitophagy, dynamics, ROS protection, light   40:11–46:22 — Pillar 1 (part 1): ETC mechanics; complex I/III issues; methylene blue + taurine note   46:23–51:25 — Pillar 1 (part 2): EZ water as battery/hydration; expanding EZ with red/NIR and sauna   52:00–58:17 — Pillar 2: Mitogenesis/PGC-1α activation (exercise, fasting, cold, PQQ, urolithin A, red light)   58:19–01:00:43 — Wrap: “halfway through” + next episode teaser (pillars 3–6 + 15 applications) - Introducing BioLight Labs! For years, BioLight has been dedicated to advancing mitochondrial wellness through education, red and near-infrared light therapy, methylene blue, and targeted nutritional solutions.   Today, we’re excited to introduce BioLight Labs — our new research-focused division dedicated to cutting-edge peptides, bioenergetics, longevity, and advanced mitochondrial science.   Our initial offerings will focus on some of the most promising peptides in the fields of healthy aging, cellular resilience, recovery, and mitochondrial function, with many more innovative compounds and educational resources to come.   BioLight Labs was created to serve researchers, practitioners, and health enthusiasts seeking the next frontier of bioenergetic optimization.   The future of wellness is bioenergetic. The future is BioLight Labs.   Explore BioLight Labs → - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

    1h 2m

  7. Jun 3

    Mitoredox: The “Electron Flow” Master Switch Behind Aging, Disease, and Mitochondrial Collapse

    This Deep Dive breaks down a preprint review from Free Radical Biology & Medicine titled “Mitoredox Shifts in Mitochondrial Dysfunction.” Dr. Mike opens with a TL;DR and then goes deeper into the core idea: a “mitoredox shift” (a disruption in mitochondrial redox balance) may be the unifying axis linking oxidative stress to mitochondrial quality-control failure, genome instability, heteroplasmy drift, and regulated cell death. The episode draws a clean line between primary genetic mitochondrial syndromes and far more common secondary mitochondrial dysfunction driven by environmental/metabolic stressors, then explores five big concepts: why redox imbalance collapses mitophagy and mtDNA stability, how “healthy” mitochondria can become hyperactive and accelerate disease, the 60–80% heteroplasmy tipping point, the reperfusion paradox, and emerging frontiers like mitochondrial transplantation, AI-driven oculomics, and new redox-modulating drugs — plus Dr. Mike’s “mitochondrial triad” lens (red light, methylene blue, C60). (Educational content only, not medical advice.) - Article Discussed in Episode: Mitoredox shifts in mitochondrial dysfunction - Key Quotes From Dr. Mike: “Mito-redox shifts… serve as a central link between oxidative stress and various diseases.” “These shifts destabilize essential cellular processes such as mitophagy and mitochondrial DNA stability…” “We are entering an era of mito redox medicine where we manage the electron flow of life itself.” “The retina is the only part of the central nervous system that can be imaged non-invasively… Whereby fluorescence imaging can detect metabolic failures years before physical symptoms appear… that is game changing.” “Life is defined by the steady controlled flow of electrons… when that flow is disrupted… our mitoredox shifts towards mitochondrial dysfunction and, ultimately, disease." - Key Points The review frames mitoredox shifts as a central link between oxidative stress and diverse diseases. Distinguishes primary mitochondrial syndromes (genetic) vs secondary disorders (environmental/metabolic)—with secondary being far more common. Mitoredox shifts destabilize mitophagy + mtDNA stability, leading to dysfunctional organelle buildup and cell death. The shift acts like an upstream master switch, biasing cells toward regulated death programs (e.g., ferroptosis, cuproptosis). “Healthy mitochondria can be hyperactive”: compensatory overwork can spike ROS and accelerate heteroplasmic drift. Heteroplasmy threshold: symptoms often emerge when mutated mtDNA crosses ~60–80%. Proposed takeover mechanisms: faster replication of truncated genomes, mitophagy decline, “survival of the sickest” evasion, random drift. Reperfusion paradox: restoring oxygen after ischemia can trigger a ROS surge that worsens injury and inflammation. Diagnostics: biomarkers + retinal imaging/oculomics, with AI methods potentially detecting dysfunction yearsearly. Therapeutics: mitochondrial transplantation, novel redox modulators (e.g., PMX 500FI), and “electron-flow stabilization” strategies. - Episode timeline 0:00–0:20 — Intro + review title + journal + preprint context (publishing Sept 2026) 0:20–1:22 — New format: TL;DR first, then deeper dive 1:22–2:56 — TL;DR: mitoredox shifts as the bridge between oxidative stress and disease; primary vs secondary; diagnostics + therapies; goal = restore homeostasis 3:00–5:01 — Mythology + endosymbiosis framing: “bioenergetic fire,” mitochondria as life/death controllers 5:01–6:58 — Concept 1: Mitoredox shift as the “unified field theory” linking ROS/antioxidants, QC failure, genome instability, regulated cell death 7:03–9:05 — Concept 2: “Healthy mitochondria” hyperactivity + metabolic asymmetry + heteroplasmic drift 9:05–11:59 — Concept 3: 60–80% tipping point; takeover mechanisms; aerobic glycolysis as a “stealth” adaptation 11:59–13:38 — Concept 4: reperfusion paradox; ROS overload → vascular destabilization + inflammation; eye/oculomics relevance 13:41–18:26 — Concept 5: future interventions—mito transplantation, AI oculomics, redox drugs (PMX 500FI) + Mike’s redox “triad” (RLT/MB/C60) 18:26–19:25 — Closing: mitochondria as redox arbiters; “electron flow of life” question + final thought - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

    21 min

  8. Jun 2

    The “Missing Peptides” Behind AFib: Humanin + MOTS-c and the Fibrosis Switch

    Atrial fibrillation is typically treated like an electrical glitch — rate control, rhythm control, anticoagulation. But this Deep Dive explores a newer frame: AFib may be driven by metabolic collapse and fibrotic remodeling rooted in mitochondrial dysfunction. Dr. Mike breaks down a May 5 Biomedicines paper titled “Humanin and MOTS-c attenuate atrial fibrillation by suppressing fibrosis and mitochondrial dysfunction,” highlighting why mitochondrial-derived peptides (MDPs) — Humanin and MOTS-c — may function as stress-responsive guardians that help preserve mitochondrial integrity, reduce oxidative stress, and blunt fibrosis. You’ll hear the key human tissue findings (both peptides downregulated in AFib atrial appendages), the biomarker signal (plasma MOTS-c inversely tracking NT-proBNP), the “Humanin paradox” (plasma up while atrial tissue down), and the mouse data showing peptide treatment reduced AFib inducibility and structural remodeling. The episode closes with a big question: if heart health is about fueling cellular engines, not just fixing wiring, how does that reshape aging medicine? (Educational content only, not medical advice.) - Article Discussed in Episode: Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction - Key Quotes From Dr. Mike: “For decades, the medical establishment has approached AFib as an electrical failure…The true culprit may not be the wiring, but rather the power plants.” “In patients with atrial fibrillation, these protective peptides essentially vanish... The more severe the peptide depletion, the more advanced the structural damage appeared to be.” “Our study identifies down regulation of Humanin and MOTS-c as a novel feature of human afib that correlates with fibrosis... As Humanin and MOTS-c levels drop, collagen deposition and atrial fibrosis increase.” “Humanin predominantly influences cell adhesion and immune response pathways, while mots C targets metabolic processes... They effectively attenuated structural remodeling and significantly reduced afib inducibility…” “These micropeptides are born directly within the mitochondrial DNA... They are exercise sensitive myokines, meaning physical activity naturally stimulates their production.” - Key Points The featured paper (May 5, Biomedicines): Humanin + MOTS-c attenuate AFib by suppressing fibrosis and mitochondrial dysfunction. AFib is framed as a growing societal burden and a driver of stroke/heart failure; current therapies mainly manage the “wiring.” Humanin + MOTS-c are mitochondrial-derived peptides encoded in mtDNA, acting as cytoprotective stress messengers. AFib atrial tissue shows significant downregulation of both peptides (spatial transcriptomics + histology). Severity link: more depletion → more structural damage/fibrosis. Biomarker link: plasma MOTS-c is decreased and inversely correlates with NT-proBNP. The “Humanin paradox”: Humanin depleted in atrial tissue but slightly elevated in plasma — blood levels can mislead. In a mouse model, HNG (Humanin analog) + MOTS-c reduced AFib inducibility and structural remodeling. Mechanistic themes: preserved mitochondrial ultrastructure, normalized fission dynamics, reduced hypertrophy, lowered IL-1β and IL-6. Dual-pronged fibroblast control: Humanin influences adhesion/immune pathways, MOTS-c targets metabolic pathways. - Episode timeline 0:00–0:57 — Intro: peptide-focused season; “future of mitochondrial medicine” 0:57–2:32 — Paper setup + personal relevance; why AFib is a mitochondria-dense tissue problem 2:32–3:50 — Reframing AFib: from electrical “wiring” to mitochondrial “power plants” + micropharmacology 3:50–4:56 — Humanin + MOTS-c basics: mtDNA-encoded “guardians,” exercise-sensitive signaling 4:56–6:51 — Human atrial tissue findings: downregulation, severity correlation, MOTS-c vs NT-proBNP 6:51–7:56 — Fibrosis link + RAAS context; peptides as complementary anti-scarring pathway 7:56–9:47 — Mouse model: HNG + MOTS-c outcomes (ultrastructure, fission, hypertrophy, cytokines) 9:47–11:15 — The Humanin paradox: plasma vs tissue concentration; biomarker caution 11:15–12:20 — Fibroblast behavior + RNA-seq: Humanin vs MOTS-c “two angles” 12:20–13:26 — Synthesis + limitations + closing question (“fueling the cell” paradigm) - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook

    15 min
See All (354)

4.8
out of 5
128 Ratings

About

The Energy Code is your blueprint for unlocking limitless vitality at the cellular level. Hosted by Dr. Mike Belkowski, this podcast dives deep into the science of your mitochondria—the true engines of health and energy. From light, water, and magnetism to groundbreaking molecules and lifestyle upgrades, each episode decodes the most effective strategies to strengthen your “Mitochondrial Matrix.” If you’re seeking cutting-edge science, practical tools, and proven methods to optimize your body and mind, you’ve just cracked the code. Check out these sources: www.biolight.shop – Instagram @biolight.shop – YouTube BioLight

Information

  • Creator
    Dr. Mike Belkowski
  • Years Active
    2021 - 2026
  • Episodes
    354
  • Rating
    Clean
  • Copyright
    © Copyright 2021 All rights reserved.
  • Show Website
    The Energy Code

You Might Also Like